{"id":"ifosfamid","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Alopecia","drugRate":"89.6%","severity":"common","organSystem":""},{"effect":"Nausea/Vomiting","drugRate":"46.8%","severity":"common","organSystem":""},{"effect":"Hematuria (without mesna)","drugRate":"44.1%","severity":"common","organSystem":""},{"effect":"Leukopenia <1 x 103/µL","drugRate":"43.5%","severity":"common","organSystem":""},{"effect":"Anemia","drugRate":"37.9%","severity":"common","organSystem":""},{"effect":"Hematuria (with mesna)","drugRate":"21.3%","severity":"common","organSystem":""},{"effect":"Central nervous system toxicity","drugRate":"15.4%","severity":"common","organSystem":""},{"effect":"Macrohematuria (without mesna)","drugRate":"11.1%","severity":"common","organSystem":""},{"effect":"Infection","drugRate":"9.9%","severity":"common","organSystem":""},{"effect":"Thrombocytopenia <50 x 103/µL","drugRate":"4.8%","severity":"common","organSystem":""},{"effect":"Phlebitis","drugRate":"2.8%","severity":"common","organSystem":""},{"effect":"Hepatotoxicity","drugRate":"1.8%","severity":"common","organSystem":""},{"effect":"Neutropenic fever","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Anorexia","drugRate":"1.1%","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"0.7%","severity":"common","organSystem":""},{"effect":"Peripheral neuropathy","drugRate":"0.4%","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"0.3%","severity":"common","organSystem":""},{"effect":"Hypotension","drugRate":"0.3%","severity":"common","organSystem":""},{"effect":"Stomatitis","drugRate":"0.3%","severity":"common","organSystem":""},{"effect":"Dermatitis","drugRate":"0.08%","severity":"common","organSystem":""}],"contraindications":["Anemia","Bone Metastases","Bone marrow depression","Breastfeeding (mother)","CNS Toxicity","Cancer Chemotherapy Induced Hemorrhagic Cystitis","Coma","Dehydration","Disease of liver","Fanconi syndrome","Hyperbilirubinemia","Hypokalemia","Impaired cognition","Impaired wound healing","Kidney disease","Kidney excision","Leukopenia","Liver function tests abnormal","Polyneuropathies","Pregnancy, function","Renal tubular acidosis","Severe Bone Marrow Depression","Thrombocytopenic disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Cardiotoxicity","drugRate":"0.5%","severity":"serious"},{"effect":"Macrohematuria (with mesna)","drugRate":"5.2%","severity":"serious"},{"effect":"Thrombocytopenia with bleeding (fatal outcome reported)","drugRate":"","severity":"serious"},{"effect":"Encephalopathy with coma and death","drugRate":"","severity":"serious"},{"effect":"Hemorrhagic cystitis","drugRate":"","severity":"serious"},{"effect":"Renal dysfunction","drugRate":"","severity":"serious"},{"effect":"Renal structural damage","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1024","moleculeType":"Small molecule","molecularWeight":"261.09"},"aliases":["Ifex"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"91e433a9-6800-43a6-ac13-a49a04a5aecd","title":"IFOSFAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]"},"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-28T03:50:49.893Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Testicular Germ Cell Tumor","diseaseId":"testicular-germ-cell-tumor","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01481272","phase":"PHASE2","title":"Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients","status":"COMPLETED","sponsor":"Polish Lymphoma Research Group","startDate":"2011-11","conditions":"Diffuse Large B Cell Lymphoma","enrollment":77},{"nctId":"NCT02414685","phase":"PHASE2","title":"First Line TIP in Poor Prognosis TGCTs.","status":"COMPLETED","sponsor":"National Cancer Institute, Slovakia","startDate":"2015-04","conditions":"Germ Cell Tumor","enrollment":19}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":45,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Ifosfamid","genericName":"Ifosfamid","companyName":"Polish Lymphoma Research Group","companyId":"polish-lymphoma-research-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":2,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}